Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDClimb Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q2 2025 | 2 | -$0.19 | -$0.18 | -$0.19 |
| Q3 2025 | 3 | -$0.16 | -$0.13 | -$0.15 |
| Q4 2025 | 2 | -$0.16 | -$0.13 | -$0.16 |
| Q1 2026 | 2 | -$0.20 | -$0.14 | -$0.18 |
| Q2 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q4 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
Climb Bio, Inc. Earnings Date And Information
Climb Bio, Inc. last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.19 earnings per share for the quarter, missing analysts' consensus estimates of $-0.16 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Climb Bio, Inc. has generated $-2 earnings per share over the last year ($-1.53 diluted earnings per share) and currently has a price-to-earnings ratio of -2.5. Climb Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2026 based on prior year's report dates.
Climb Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 2025 | N/A | -$0.19 | N/A | $0 | $0 |
| 06/29/2025 | Q2 2025 | N/A | -$0.13 | N/A | $0 | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$0.31 | N/A | $0 | $0 |
| 12/31/2024 | Q4 2024 | N/A | -$0.13 | N/A | $0 | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.13 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$1.81 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.06 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | -$0.13 | -$0.13 | 0 | N/A | $0 |
| 09/30/2023 | Q3 2023 | -$0.14 | -$0.15 | -0.01 | N/A | $0 |
| 06/30/2023 | Q2 2023 | -$0.16 | -$0.19 | -0.03 | N/A | $0 |
| 03/31/2023 | Q1 2023 | -$0.25 | -$0.84 | -0.59 | N/A | $0 |
| 12/31/2022 | Q4 2022 | -$0.38 | -$0.29 | 0.09 | N/A | $0 |
| 09/30/2022 | Q3 2022 | N/A | -$0.37 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | -$0.43 | -$0.56 | -0.13 | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.50 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | -$0.40 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.70 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.46 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$1.69 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$1.27 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Climb Bio, Inc. Earnings: FAQ's
Climb Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2026 based offlast year's report dates.
The conference call for Climb Bio, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Climb Bio, Inc.'s latest earnings report can be read online.
Climb Bio, Inc. (:CLYM) has a recorded net income of $-73,897,000.Climb Bio, Inc. has generated $-1.53 earnings per share over the last four quarters.
Climb Bio, Inc. (:CLYM) has a price-to-earnings ratio of -2.5 and price/earnings-to-growth ratio is -0.04.